China, Enhertu, HER 2 positive
Enhertu has been approved in China for patients with HER2-positive metastatic breast cancer
Feb 2023: Enhertu (trastuzumab deruxtecan) from AstraZeneca and Daiichi Sankyo has been approved as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received ..
CAR - T Cell therapy, China, IASO Biotherapeutics, multiple myeloma
CAR T-cell treatment from IASO Biotherapeutics receives new FDA approval
Feb 2023: IASO Biotherapeutics' investigational CAR T-cell therapy for relapsed or refractory multiple myeloma (RRMM), CT103A, has received fast track and regenerative medicine advanced therapy designations from the U.S. Food and..
CAR-T therapies, chimeric antigen receptors, China, ciltacabtagene autoleucel, Janssen Biotech, Legend biotech
CARVYKTI (ciltacabtagene autoleucel), BCMA-Directed CAR-T Therapy, receives U.S. FDA approval for the treatment of adult patients with relapsed or refractory multiple myeloma
March 2022: According to Johnson & Johnson, a therapy developed by the company and its China-based partner Legend Biotech Corp to treat a kind of white blood cell cancer has been approved by the US Food and Drug Administrati..
China, Chongqing, Professor Qian Cheng, University of Pennsylvania
Patient in China achieves complete remission from leukemia after CAR T-Cell therapy
Feb 2022: In China, a patient whose life was on the verge of ending was entirely healed of leukaemia thanks to CAR T-cell therapy, which stimulated the immune system. All cancer cells vanished swiftly in the first study of its kin..
CAR - T Cell therapy, CAR T, CAR T Cell therapy in China, CAR T-Cell, China, Treatment in China
China-based CAR-T Cell therapy achieves breakthrough clinical trial results
June 2016: Professor Huang He of Zhejiang University's First Affiliated Hospital presented the outcomes of 10 clinical cases, including CAR-T cell therapy for leukaemia treatment, at the 2016 Haematogenic Immunity Summit in Hangz..
CAR-T cells, chimeric antigen receptors, China, China CAR T therapy, Chongqing
CAR T-Cell therapy saves leukemia patient in China
Feb 2022: A 12-year-old girl from southwest China's Chongqing Municipality was saved by an unconventional therapy instead of chemotherapy or hematopoietic stem cell transplantation.Yi Mengdie has a seven-month medical history and ..
CAR - T Cell therapy, China, India, Treatment, USA
A new strategy for immunotherapy of multiple myeloma
In recent decades, monoclonal antibody-based cancer treatment has been established as one of the most successful treatment strategies for solid tumors and blood cancers. As the name implies, monoclonal antibodies (mAbs) are antibo..
China, Cost, Gastric, Gastroenterology, India, Israel, Singapore, Stomach, Treatment, USA
Continuously taking these medicines may double the risk of stomach cancer
A study published in "Intestine" showed that long-term use of proton pump inhibitors will double the risk of gastric cancer . Proton pump inhibitors are a class of drugs used to treat gastric acid reflux. ,Continuous use of thi..
China, India, Israel, Ramucirumab, Singapore, Treatment, USA
Ramucirumab in treatment of gastric cancer
According to statistics, patients with gastric cancer treated in the United States, Europe, and Japan are often recommended to use ramucirumab in combination with other drugs to treat gastric cancer.The US Food and Drug Administra..
China, Combination therapy, India, Liver, PD-1 inhibitor, Roche, USA
Roche PD-1 inhibitor liver cancer combination therapy was recognized by the FDA as a breakthrough therapy
The Swiss Roche Group announced yesterday that TECENTRIQ® (atezolizumab) in combination with Avastin® (bevacizumab) has been approved by the US Food and Drug Administration (FDA) for breakthrough therapy for initial (first-line)..